2022 SPEAKERS

 

 

Farida Abane, Senior Medical Director, Pharmacovigilance, Deciphera Pharmaceuticals Llc

Farida Abane | Senior Medical Director, Pharmacovigilance | Deciphera Pharmaceuticals Llc » speaking at Drug Safety USA

Adel Abou-Ali, Director, Risk Management & Benefit Risk, Global Pharmacovigilance, Astellas Pharma

Adel Abou-Ali | Director, Risk Management & Benefit Risk, Global Pharmacovigilance | Astellas Pharma » speaking at Drug Safety USA

Vivek Ahuja, Vice President, MACR & Global Head, Pharmacovigilance, Sun Pharmaceutical Industries Limited

Vivek Ahuja | Vice President, MACR & Global Head, Pharmacovigilance | Sun Pharmaceutical Industries Limited » speaking at Drug Safety USA

Omar Aimer, Executive Committee member of ISoP; CEO and Founder, InnoVigilance

Omar Aimer | Executive Committee member of ISoP; CEO and Founder | InnoVigilance » speaking at Drug Safety USA

Wassim Aldairy, VP, Pharmacovigilance, Mersana Therapeutics, Inc.

Paridhi Anand, Associate Director, PV Operations, ICSR Quality and Analytics, Moderna Therapeutics

Paridhi Anand | Associate Director, PV Operations, ICSR Quality and Analytics | Moderna Therapeutics » speaking at Drug Safety USA

Jason Ancell, Director, Global Patient Safety, Gilead Sciences

Jason Ancell | Director, Global Patient Safety | Gilead Sciences » speaking at Drug Safety USA

Rawad Antoun, Director, Gcsp Regions Lead, Americas, CSL Behring

Rawad Antoun | Director, Gcsp Regions Lead, Americas | CSL Behring » speaking at Drug Safety USA

Dr Nicole Baker, Chief Executive Officer, biologit

Dr Nicole Baker | Chief Executive Officer | biologit » speaking at Drug Safety USA

Greg Ball, Head of Safety Statistics, Global Vaccine Safety, Novavax

Deepak Bandyopadhyay, Interim Director, Quality Analytics Data Sciences, BioResearch Quality & Compliance (BRQC), Jassen

Khaudeja Bano, Vice President, Combination Product Quality, Amgen

Khaudeja Bano | Vice President, Combination Product Quality | Amgen » speaking at Drug Safety USA

Victoria Bartasek, Senior Associate Director, Global Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG

Melissa Bernal, Vice President, Asociación Colombiana de Farmacovigilancia

Melissa Bernal | Vice President | Asociación Colombiana de Farmacovigilancia » speaking at Drug Safety USA

Arpita Bhowmick, Director, Global Omni Channel Contact Center Technology, Digital, Moderna

Arpita Bhowmick | Director, Global Omni Channel Contact Center Technology, Digital | Moderna » speaking at Drug Safety USA

Kapil Bhutada, Director, PV Compliance and Training, Medicago

Benjamin Brown, Executive Director, American Society of Pharmacovigilance

Benjamin Brown | Executive Director | American Society of Pharmacovigilance » speaking at Drug Safety USA

Jim Buchanan, Clinician, Covilance

Siva Kumar Buddha, Global Pharmacovigilance Physician, Senior Manager, Teva Pharmaceuticals

Gloria Bustos, PhD in Pharmacy, Senior Director, Head of Pharmacovigilance, EMEA & APAC / Global Patient Safety, Baxter Healthcare

Anna Carina, Safety Compliance Principal Specialist, Novo Nordisk A/S

Mijal Chavda, Director, Global GxP Inspections & GVP Quality, Kyowa Kirin International

Michael Cheung, Senior Director, US REMS Strategy and Submissions Lead, Bristol Myers Squibb

Michael Cheung | Senior Director, US REMS Strategy and Submissions Lead | Bristol Myers Squibb » speaking at Drug Safety USA

David Chonzi, Global Head of PVE, Instil Bio

David Chonzi | Global Head of PVE | Instil Bio » speaking at Drug Safety USA

Edward Chow, Executive Director, Toxicology, AbbVie

Edward Chow | Executive Director, Toxicology | AbbVie » speaking at Drug Safety USA

Shaun Comfort, Principal Science Enablement Director, Genentech

Shaun Comfort | Principal Science Enablement Director | Genentech » speaking at Drug Safety USA

Jacqueline Corrigan-Curay, Director, Office of Medical Policy, Center for Drug Evaluation and Research, FDA

Jacqueline Corrigan-Curay | Director, Office of Medical Policy, Center for Drug Evaluation and Research | FDA » speaking at Drug Safety USA

Antonio Del Santo, Principal Medical Director Personalized Safety Interface Product Development Safety, Hoffmann La-Roche AG

Antonio Del Santo | Principal Medical Director Personalized Safety Interface Product Development Safety | Hoffmann La-Roche AG » speaking at Drug Safety USA

Marc DeLuca, M.ENG HSE, US Risk Management Lead, Sanofi

Marc DeLuca, M.ENG HSE | US Risk Management Lead | Sanofi » speaking at Drug Safety USA

Abhay Dhingra, Associate Director of Pharmacovigilance Digital Innovation, Moderna, Inc.

Abhay Dhingra | Associate Director of Pharmacovigilance Digital Innovation | Moderna, Inc. » speaking at Drug Safety USA

Christina Dickson, Head of Pharmacovigilance Operations, GSK

Christina Dickson | Head of Pharmacovigilance Operations | GSK » speaking at Drug Safety USA

Steve Dingman, VP, Drug Safety and Pharmacovigilance, Alkermes

Steve Dingman | VP, Drug Safety and Pharmacovigilance | Alkermes » speaking at Drug Safety USA

Nancy Dubois, Head of Global Patient Safety, EMD Serono

Nancy Dubois | Head of Global Patient Safety | EMD Serono » speaking at Drug Safety USA

Helen Edelberg, MD, MPH, Deputy Director of Safety, Office of New Drugs, FDA

Helen Edelberg, MD, MPH | Deputy Director of Safety, Office of New Drugs | FDA » speaking at Drug Safety USA

Kal Elhoregy, Director, Risk Evaluation and Mitigation Strategy (REMS), Amneal Pharmaceuticals

Joe Elicone, Global Head, Business Process, CSL Behring

Joe Elicone | Global Head, Business Process | CSL Behring » speaking at Drug Safety USA

Scott Fonseca, Vice President Pharmacovigilance and Regulatory Solutions, IQVIA

Scott Fonseca | Vice President Pharmacovigilance and Regulatory Solutions | IQVIA » speaking at Drug Safety USA

Jacqueline Gerena, Director, Program Management (REMS & RMP), Aimmune Therapeutics

Yvonne Gibble, Executive Director, Merck Sharp & Dohme LLC

Coryandar Gilvary, Chief Data Scientisit, OneThree Biotech

Coryandar Gilvary | Chief Data Scientisit | OneThree Biotech » speaking at Drug Safety USA

Michael Glaser, Safety Innovation Technology Director, GSK

Aaron Goodstein, Senior Director, Medical Safety Strategy and Operations, Johnson and Johnson Medical Devices

Kishore Gopu, Senior Director, REMS Operations, Teva Pharmaceuticals

Kishore Gopu | Senior Director, REMS Operations | Teva Pharmaceuticals » speaking at Drug Safety USA

Ruben Bonilla Guerrero, Chief Medical Officer, Innovative Gx Laboratories

Israel Gutierrez, VP, Drug Safety & Pharmacovigilance, Compugen Ltd

Israel Gutierrez | VP, Drug Safety & Pharmacovigilance | Compugen Ltd » speaking at Drug Safety USA

Bill Haddock, Head Of Safety, Ovid Therapeutics

Bill Haddock | Head Of Safety | Ovid Therapeutics » speaking at Drug Safety USA

Camilla Hammerum, Vice President, Global Patient Safety, Neuroscience Therapeutic Area Head, Ipsen

Rave Harpaz, Senior Director Research and Data Science, Oracle Health Sciences

Paul Hayashi, DILI Team Lead, Division of Hepatology & Nutrition, FDA

Paul Hayashi | DILI Team Lead, Division of Hepatology & Nutrition | FDA » speaking at Drug Safety USA

Barbara Hendrickson, Vice President, AbbVie

Barbara Hendrickson | Vice President | AbbVie » speaking at Drug Safety USA

Alisa Hummings, Global Head, Medical Information, Local AE Intake, and CEVA Lifecycle Safety, IQVIA

Alisa Hummings | Global Head, Medical Information, Local AE Intake, and CEVA Lifecycle Safety | IQVIA » speaking at Drug Safety USA

Raúl J. Andrade, Professor of Medicine and Director, Department of Medicine, University of Malaga

Raúl J. Andrade | Professor of Medicine and Director, Department of  Medicine | University of Malaga » speaking at Drug Safety USA

Dutrochet Jacques Djoko, Senior Manager, Global Medical Reviewer, Sarepta Therapeutics

Dutrochet Jacques Djoko | Senior Manager, Global Medical Reviewer | Sarepta Therapeutics » speaking at Drug Safety USA

Kedar Joshi, Associate Vice President - Global Client Partner, Indegene, Inc.

Leandre Kenmogne Cheteu, R&D Researcher, Zhejiang Sci-Tech University

Jerry Kounga, Investigational Drug Lead Pharmacist, Ascension Health Wisconsin

Michael Kruczek, Director, Vault Safety, Veeva Systems

Dr. Graeme Ladds, Director of Pharmacovigilance & Chief Executive Officer, PharSafer

Claudia Lehmann, Head Global Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International

Claudia Lehmann | Head Global Patient Safety & Pharmacovigilance Operations | Boehringer Ingelheim International » speaking at Drug Safety USA

Mengchun Li, Pharmacovigilance Director, T.B. Alliance

Mengchun Li | Pharmacovigilance Director | T.B. Alliance » speaking at Drug Safety USA

David Lilienfeld, MD, Vice President, Drug Safety and Pharmacovigilance, Elevar Therapeutics

David Lilienfeld, MD | Vice President, Drug Safety and Pharmacovigilance | Elevar Therapeutics » speaking at Drug Safety USA

Bruno Mendez, VP, Global quality PV, Sanofi

Sherice Mills, Executive Director, Head of Risk Management – US & Canada, Jazz Pharmaceuticals

Sherice Mills | Executive Director, Head of Risk Management – US & Canada | Jazz Pharmaceuticals » speaking at Drug Safety USA

Ellen (Lena) Mishalov, Director, Pv Technological Innovations, Astellas Pharma

Ellen (Lena) Mishalov | Director, Pv Technological Innovations | Astellas Pharma » speaking at Drug Safety USA

Andrew Mitchell, Senior Director, Pharmacovigilance & Regulatory Technology Solutions, IQVIA

Andrew Mitchell | Senior Director, Pharmacovigilance & Regulatory Technology Solutions | IQVIA » speaking at Drug Safety USA

Madhu Mondal, Senior Director, Safety Assessment, Cerevel Therapeutics

Andrew A. Monte, MD, PhD,, Professor of Emergency Medicine & Medical Toxicology, University of Colorado Hospital, Medical Director, Rocky Mountain Poison & Drug Safety Center (RMPDS)

Andrew A. Monte, MD, PhD, | Professor of Emergency Medicine & Medical Toxicology, University of Colorado Hospital, Medical Director | Rocky Mountain Poison & Drug Safety Center (RMPDS) » speaking at Drug Safety USA

Deanna Montes De Oca, Senior Director, PV Operations-Global Case Management, Moderna Therapeutics

Barbara Morollo, Executive Director and Head of Global Safety Science, Ultragenyx Pharmaceutical

Muhammad Ashar Naeem, Global Director, Head of Pharmacovigilance and Medical Affairs Department, Jamjoom Pharma

Muhammad Ashar Naeem | Global Director, Head of Pharmacovigilance and Medical Affairs Department | Jamjoom Pharma » speaking at Drug Safety USA

Jaylaxmi Nalawade, Associate Director - Pharmacovigilance and REMS, Lupin Inc.

Jaylaxmi Nalawade, Associate Director, Lupin Pharmaceuticals

Oyinkansola Odebo, Assistant Director Drug Safety, Supernus Pharmaceutical

Oyinkansola Odebo | Assistant Director Drug Safety | Supernus Pharmaceutical » speaking at Drug Safety USA

Nneka Okere, Senior Director, Pharmacovigilance, Nurix Therapeutics

Bruce Palsulich, Vice President of Safety Product Strategy, Oracle Health Sciences

Bruce Palsulich | Vice President of Safety Product Strategy | Oracle Health Sciences » speaking at Drug Safety USA

Badrish Patel, M.D., Vice President, Head of Safety, AlloVir

Badrish Patel, M.D. | Vice President, Head of Safety | AlloVir » speaking at Drug Safety USA

Vladimir Penkrat, Associate Vice President - Global Head of Safety & Regulatory Affairs, Indegene, Inc.

Sridevi Ponduru, Senior Medical Director, Global Patient Safety Evaluation, Takeda Pharmaceuticals USA Inc

Sridevi Ponduru | Senior Medical Director, Global Patient Safety Evaluation | Takeda Pharmaceuticals USA Inc » speaking at Drug Safety USA

Humaira Qureshi, CEO, Qinecsa Solutions

Sara Rogers,PharmD, BCPS, President, American Society of Pharmacovigilance

Sara Rogers,PharmD, BCPS | President | American Society of Pharmacovigilance » speaking at Drug Safety USA

Maha Saad, Senior Director Drug Safety and Pharmacovigilance, Atara Biotherapeutics

Maha Saad | Senior Director Drug Safety and Pharmacovigilance | Atara Biotherapeutics » speaking at Drug Safety USA

Satya Sagi, Founder & Chief Executive Officer, Techsol Life Sciences

Satya Sagi | Founder & Chief Executive Officer | Techsol Life Sciences » speaking at Drug Safety USA

Milind Sardesai, Senior Director & Head, Pharmacovigilance, Covis Pharma

Milind Sardesai | Senior Director & Head, Pharmacovigilance | Covis Pharma » speaking at Drug Safety USA

Dr. Linda J Scarazzini, Vice President, Pharmacovigilance & Patient Safety, AbbVie

Philip Schneider, Advisory Board Chair, Alliance for Safe Biologic Medicines

Philip Schneider | Advisory Board Chair | Alliance for Safe Biologic Medicines » speaking at Drug Safety USA

Vipin Sethi, Head Of Global Pharmacovigilance And Medical Affairs, Cadila Pharmaceuticals

Vipin Sethi | Head Of Global Pharmacovigilance And Medical Affairs | Cadila Pharmaceuticals » speaking at Drug Safety USA

Amgad Shebl, Senior Director, Global Safety Lead, Immunology, CSL Behring

Amgad Shebl | Senior Director, Global Safety Lead, Immunology | CSL Behring » speaking at Drug Safety USA

Aarekh Shrestha, Head of Pharmacovigilance, Veranex

Aarekh Shrestha | Head of Pharmacovigilance | Veranex » speaking at Drug Safety USA

Prashant Sonar, Senior Manager, Pharmacovigilance Operations Compliance, Incyte Corp.

Mariette Boerstoel Streefland, Senior Vice President Patient Safety, Chief Safety Officer, AstraZeneca

Mariette Boerstoel Streefland | Senior Vice President Patient Safety, Chief Safety Officer | AstraZeneca » speaking at Drug Safety USA

Alan Summer, Vice President, Pharmacovigilance Services, Astrix Technology Inc

Marina Suvakov, Global Head Safety Surveillance, Philip Morris International

Tarak Thakker, Director, Safety Systems, BeiGene USA, Inc.

Tarak Thakker | Director, Safety Systems | BeiGene USA, Inc. » speaking at Drug Safety USA

Siva Thiagarajan, Safety Practice Lead, ZS

Phil Tregunno, Head of Vigilance Operations, Medicines & Healthcare Products Regulatory Agency

Phil Tregunno | Head of Vigilance Operations | Medicines & Healthcare Products Regulatory Agency » speaking at Drug Safety USA

Liliana Vargas Neri, Secretary of Executive Committee of Latin American Chapter, International Society of Pharmacovigilance

Liliana Vargas Neri | Secretary of Executive Committee of Latin American Chapter | International Society of Pharmacovigilance » speaking at Drug Safety USA

Dennis Vargo, Vice President, Head Of Drug Safety And Pharmacovigilance, Akebia Therapeutics , Inc.

Dennis Vargo | Vice President, Head Of Drug Safety And Pharmacovigilance | Akebia Therapeutics , Inc. » speaking at Drug Safety USA

Tina Veizovic, Senior Director, Global Patient Safety Business Strategy, Planning and Execution, BeiGene

Tina Veizovic | Senior Director, Global Patient Safety Business Strategy, Planning and Execution | BeiGene » speaking at Drug Safety USA

Padma Vellanki, Director of Worldwide Patient Safety and Global Regulatory Data Analytics, Bristol-Myers Squibb

Padma Vellanki | Director of Worldwide Patient Safety and Global Regulatory Data Analytics | Bristol-Myers Squibb » speaking at Drug Safety USA

Ram Vempati, Head of Pharmacovigilance, Arcellx Inc

Ram Vempati | Head of Pharmacovigilance | Arcellx Inc » speaking at Drug Safety USA

Deepa Venkataraman, Head of Global Patient Safety/PV and QA, Summit Therapeutics Inc

Deepa Venkataraman | Head of Global Patient Safety/PV and QA | Summit Therapeutics Inc » speaking at Drug Safety USA

Michael von Forstner, Head of Clinical Safety and Pharmacovigilance, Biosimilars, Biogen

Michael von Forstner | Head of Clinical Safety and Pharmacovigilance, Biosimilars | Biogen » speaking at Drug Safety USA

Marcin von Grotthuss, Principal Scientist, Investigative Toxicology, Takeda

Bianca Vora, Clinical Pharmacology Scientist, Genentech

Bianca Vora | Clinical Pharmacology Scientist | Genentech » speaking at Drug Safety USA

Dany Ward, Senior Director, Clinical Safety and Risk Management, AlloVir

Dany Ward | Senior Director, Clinical Safety and Risk Management | AlloVir » speaking at Drug Safety USA

Max Waschbusch, TA Head Cardiovascular and Metabolism, CSL Behring

Susan Welsh MD, Senior Vice President, PV & Chief Safety Officer, Mirati Therapeutics

Susan Welsh MD | Senior Vice President, PV & Chief Safety Officer | Mirati Therapeutics » speaking at Drug Safety USA

Richard Wolf, Executive Director, C.S.L. Behring Gmbh

Richard Wolf | Executive Director | C.S.L. Behring Gmbh » speaking at Drug Safety USA

Yuli Wu, Executive Director and Head of Drug Safety and Pharmacovigilance, Zai Lab

Yuli Wu | Executive Director and Head of Drug Safety and Pharmacovigilance | Zai Lab » speaking at Drug Safety USA

Andrew Yazwa, Risk Management Lead, Janssen

Andrew Yazwa | Risk Management Lead | Janssen » speaking at Drug Safety USA

Syed Zaferuddin, Global Pharmacovigilance Manager and QPPV, Julphar

Syed Zaferuddin | Global Pharmacovigilance Manager and QPPV | Julphar » speaking at Drug Safety USA

Patricia Zuluaga Arias, President, Asociación Colombiana de Farmacovigilancia

Patricia Zuluaga Arias | President | Asociación Colombiana de Farmacovigilancia » speaking at Drug Safety USA

 

 

 

Get Involved At Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Semen Sen
Semen.sen@terrapinn.com
t/ +1 646 619 1793

 

 

To Speak


Semen Sen
semen.sen@terrapinn.com
t/ +1 646 619 1793

 

 

Marketing & Press Opportunities


Taylor Post
taylor.post@terrapinn.com
t/ +1 646 619 1785